227 related articles for article (PubMed ID: 32776979)
21. Psychopathology, social adjustment and personality correlates of schizotypy clusters in a large nonclinical sample.
Barrantes-Vidal N; Lewandowski KE; Kwapil TR
Schizophr Res; 2010 Sep; 122(1-3):219-25. PubMed ID: 20138738
[TBL] [Abstract][Full Text] [Related]
22. The schizotypal ambivalence scale as a marker of schizotypy.
Mann MC; Vaughn AG; Barrantes-Vidal N; Raulin ML; Kwapil TR
J Nerv Ment Dis; 2008 May; 196(5):399-404. PubMed ID: 18477882
[TBL] [Abstract][Full Text] [Related]
23. Comparing the factor structure of the Wisconsin Schizotypy Scales and the Schizotypal Personality Questionnaire.
Gross GM; Mellin J; Silvia PJ; Barrantes-Vidal N; Kwapil TR
Personal Disord; 2014 Oct; 5(4):397-405. PubMed ID: 25314229
[TBL] [Abstract][Full Text] [Related]
24. Prediction of prodromal symptoms and schizophrenia-spectrum personality disorder traits by positive and negative schizotypy: A 3-year prospective study.
Racioppi A; Sheinbaum T; Gross GM; Ballespí S; Kwapil TR; Barrantes-Vidal N
PLoS One; 2018; 13(11):e0207150. PubMed ID: 30408119
[TBL] [Abstract][Full Text] [Related]
25. Psychometric properties of the Brief Version of the Schizotypal Personality Questionnaire in relatives of patients with schizophrenia-spectrum disorders and non-psychiatric controls.
Compton MT; Chien VH; Bollini AM
Schizophr Res; 2007 Mar; 91(1-3):122-31. PubMed ID: 17258893
[TBL] [Abstract][Full Text] [Related]
26. Childhood schizotypy and positive symptoms in schizophrenic patients predict schizotypy in relatives.
Mata I; Sham PC; Gilvarry CM; Jones PB; Lewis SW; Murray RM
Schizophr Res; 2000 Aug; 44(2):129-36. PubMed ID: 10913744
[TBL] [Abstract][Full Text] [Related]
27. Validation of the Chinese version of the Multidimensional Schizotypy Scale (MSS): Convergent evidence from exploratory and confirmatory factor analyses.
Zou YM; Yang HX; Zhang RT; Lui SSY; Cheung EFC; Chan RCK
Asian J Psychiatr; 2020 Jun; 51():102057. PubMed ID: 32305866
[TBL] [Abstract][Full Text] [Related]
28. [French validation of the Revised Paranormal Belief Scale].
Bouvet R; Djeriouat H; Goutaudier N; Py J; Chabrol H
Encephale; 2014 Sep; 40(4):308-14. PubMed ID: 24836860
[TBL] [Abstract][Full Text] [Related]
29. Cognitive profiles of schizotypal dimensions in a community cohort: Common properties of differential manifestations.
Karagiannopoulou L; Karamaouna P; Zouraraki C; Roussos P; Bitsios P; Giakoumaki SG
J Clin Exp Neuropsychol; 2016 Nov; 38(9):1050-63. PubMed ID: 27295077
[TBL] [Abstract][Full Text] [Related]
30. The multidimensionality of schizotypy.
Vollema MG; van den Bosch RJ
Schizophr Bull; 1995; 21(1):19-31. PubMed ID: 7770738
[TBL] [Abstract][Full Text] [Related]
31. Psychometric properties and concurrent validity of the schizotypal ambivalence scale.
Kwapil TR; Mann MC; Raulin ML
J Nerv Ment Dis; 2002 May; 190(5):290-5. PubMed ID: 12011608
[TBL] [Abstract][Full Text] [Related]
32. A multimodal imaging study of brain structural correlates of schizotypy dimensions using the MSS.
Pfarr JK; Nenadić I
Psychiatry Res Neuroimaging; 2020 Aug; 302():111104. PubMed ID: 32474373
[TBL] [Abstract][Full Text] [Related]
33. Typology of schizotypy in non-clinical young adults: Psychopathological and personality disorder traits correlates.
Raynal P; Goutaudier N; Nidetch V; Chabrol H
Psychiatry Res; 2016 Dec; 246():182-187. PubMed ID: 27718467
[TBL] [Abstract][Full Text] [Related]
34. The relationship between schizotypal ideation and subjective cognition reflects more than just cognitive disorganisation: introducing the Brief Cognitive Schizotypy Index.
Corcoran R; Devan K; Durrant S; Liddle P
Cogn Neuropsychiatry; 2013; 18(6):491-514. PubMed ID: 23193969
[TBL] [Abstract][Full Text] [Related]
35. The expression of positive and negative schizotypy in daily life: an experience sampling study.
Kwapil TR; Brown LH; Silvia PJ; Myin-Germeys I; Barrantes-Vidal N
Psychol Med; 2012 Dec; 42(12):2555-66. PubMed ID: 22716971
[TBL] [Abstract][Full Text] [Related]
36. Comparison of self-report and clinician-rated schizotypal traits in schizotypal personality disorder and community controls.
Chan CC; Bulbena-Cabre A; Rutter S; Benavides C; McClure MM; Calabrese W; Rosell DR; Koenigsberg HW; Goodman M; New AS; Hazlett EA; Mercedes Perez-Rodriguez M
Schizophr Res; 2019 Jul; 209():263-268. PubMed ID: 30635257
[TBL] [Abstract][Full Text] [Related]
37. Common Taxonomy of Traits and Symptoms: Linking Schizophrenia Symptoms, Schizotypy, and Normal Personality.
Cicero DC; Jonas KG; Li K; Perlman G; Kotov R
Schizophr Bull; 2019 Oct; 45(6):1336-1348. PubMed ID: 30753725
[TBL] [Abstract][Full Text] [Related]
38. Schizotypal symptoms and signs in the Roscommon Family Study. Their factor structure and familial relationship with psychotic and affective disorders.
Kendler KS; McGuire M; Gruenberg AM; Walsh D
Arch Gen Psychiatry; 1995 Apr; 52(4):296-303. PubMed ID: 7702446
[TBL] [Abstract][Full Text] [Related]
39. Schizotypal personality questionnaire--brief revised (updated): An update of norms, factor structure, and item content in a large non-clinical young adult sample.
Davidson CA; Hoffman L; Spaulding WD
Psychiatry Res; 2016 Apr; 238():345-355. PubMed ID: 27086255
[TBL] [Abstract][Full Text] [Related]
40. Schizotypy and nicotine, alcohol, and cannabis use in a non-psychiatric sample.
Esterberg ML; Goulding SM; McClure-Tone EB; Compton MT
Addict Behav; 2009 Apr; 34(4):374-9. PubMed ID: 19136217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
